MDPI and ACS Style Zhang, C.-X.; Lou, Y.; Chi, J.; Bao, X.-L.; Fan, B.; Li, G.-Y. Considerations for the Use of Photobiomodulation in the Treatment of Retinal Diseases. Biomolecules 2022, 12, 1811. https://doi.org/10.3390/biom12121811, AMA Style Zhang C-X, Lou Y, Chi J, Bao X-L, Fan B, Li G-Y. Considerations for the Use of Photobiomodulation in the Treatment of Retinal Diseases. Biomolecules. 2022; 12(12):1811. https://doi.org/10.3390/biom12121811, Chicago/Turabian Style Zhang, Chun-Xia, Yan Lou, Jing Chi, Xiao-Li Bao, Bin Fan, and Guang-Yu Li. 2022. "Considerations for the Use of Photobiomodulation in the Treatment of Retinal Diseases" Biomolecules 12, no. 12: 1811. https://doi.org/10.3390/biom12121811

Department of Mechanical Engineering, Pohang University of Science and Technology (POSTECH), Pohang 37673, Korea, 2 Department of Ophthalmology and Visual Science, Eunpyeong St. Mary’s Hospital, The Catholic University of Korea, Seoul 03312, Korea, 3 Catholic Institute for Visual Science, College of Medicine, The Catholic University of Korea, Seoul 14662, Korea * Author to whom correspondence should be addressed.

(This article belongs to the Special Issue Energy Metabolism in Health and Disease)

UCL Home, UCL News, Morning exposure to deep red light improves declining eyesight

Received: 21 February 2020 / Revised: 21 March 2020 / Accepted: 27 March 2020 / Published: 30 March 2020 (This article belongs to the Special Issue CNS Drug Action in Neurodegenerative Diseases)

Private Practice, Fox Vision Development Center, 1202 Troy Schenectady Road, Latham, NY 12110, USA; b Pappas Rehabilitation Hospital for Children, 7 Cedar Drive, Canton, MA 02021, USA

Investigative Ophthalmology & Visual Science June 2023, Vol.64, 3696. doi: